Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1009 results for "usfda"

Orchid Chemicals surges on USFDA nod
India Infoline

Orchid Chemicals surges on USFDA nod

The company has received US Food and Drug Administration (USFDA) nod for hypertension drug Felodipine. India Infoline, 12 hours ago
Orchid Chemicals surges 2% on USFDA nod India Infoline, 6 hours ago

52 images for usfda

Money Today, 6 days ago
India Infoline, 6 hours ago
Business Standard, 23 hours ago, 5 days ago
India Infoline, 6 days ago
One India, 6 days ago
India Infoline, 1 week ago
Business Standard, 1 week ago
Money Today, 3 weeks ago
Money Control, 3 weeks ago
India Infoline

USFDA completes Waluj facility inspection: Wockhardt

Wockhardt, which has been under the USFDA's scanner, today said that the American health regulator has completed the inspection of its Waluj facility in Maharashtra. "Inspection of our manufacturing unit at H14/2 Waluj, Aurangabad, Maharashtra by United ...
 Business Standard1 day ago Wockhardt rises 11%; USFDA completes Waluj inspection  Money Control1 day ago Wockhardt soars over 11%  India Infoline1 day ago US Regulator Completes Waluj Facility Inspection: Wockhardt  NDTV Profit1 day ago
Business Standard

Claris' sale plan may hit roadblock as USFDA slams form 483 to its facility

Ahmedabad-based injectables player Claris Lifescience's plans to sell its generic sterile injectables business might hit a roadblock as its US Food and Drug Administration (USFDA) approved site at Ahmedabad has recently received a 483 observation ...
 Business Standard India1 day ago

Wockhardt surges as USFDA completes inspection in two Maharashtra plants

By ECONOMICTIMES.COM | 27 May, 2015, 02.08PM IST Post a Comment NEW DELHI: Shares of Wockhardt Ltd surged as much as 11.57 per cent in intraday trade on Wednesday on media reports that US Food and Drug Administration (FDA) had completed its inspection at its ...
 Economic Times1 day ago
Money Today

Glenmark gets USFDA approval to sell Rufinamide

Glenmark Pharmaceuticals on Thursday said it has been granted tentative approval by the US health regulator to sell Rufinamide, which is used to treat seizures caused by Lennox-Gastaut syndrome. Lennox-Gastaut syndrome is a form of childhood-onset epilepsy.
 Money Today1 week ago Glenmark gets USFDA nod to sell Rufinamide  Press Trust of India1 week ago Glenmark Pharmaceuticals receives USFDA approval for Rufinamide Tablets USP  Finalaya.com1 week ago Glenmark Pharma gets tentative ANDA approval for Rufinamide Tablets USP  Money Control1 week ago

First drug to treat radiation sickness gets USFDA nod

The first drug that can safely and effectively treat the nasty effects of severe radiation exposure following a nuclear disaster has been approved by US health-watchdog. The drug, Neupogen, long-used to counter the negative effects of chemotherapy, ...
 Business Standard2 days ago

Mid-cap pharma shares slide as investors book profit after recent upsurge

The sector faces near-term headwinds such as a slower-than-expected pick up in the USFDA approvals and currency volatility The post Mid-cap pharma shares slide as investors book profit after recent upsurge appeared first on Firstpost .
 First Post.com3 days ago
Business Standard

Strides Arcolab gets USFDA nod for new tablets

. Lamivudine and Zidovudine are generic version of Viiv's Combivir that belong to a group of antiviral medicines, also known as antiretrovirals and is used with other anti retroviral medicines to treat HIV infection in adults and children. Lamivudine and ...
 Business Standard1 week ago Strides Arcolab gains on USFDA nod for Lamivudine and Zidovudine tablets  Smart Investor1 week ago Strides Arcolab receives ANDA approval from USFDA  Money Control1 week ago Strides Arcolab soars on receiving USFDA approval for Lamivudine, Zidovudine tablets  Arihant Capital1 week ago
India Infoline

Wockhardt jumps after getting nod from USFDA

The company has announced USFDA has granted WCK 4873, a product from their New Drug Discovery program, QIDP status. Wockhardt is currently trading with a surge of 2.3 percent at Rs. 1,440 on the BSE, on the back of positive news flow. According to a release ...
 India Infoline6 days ago Wockhardt receives QIDP status from USFDA  Money Control1 week ago Wockhardt gains on receiving QIDP designation for its new drug WCK 4873 from USFDA  Arihant Capital6 days ago Wockhardt receives QIDP designation for its new drug WCK 4873 from USFDA  Indian-Commodity6 days ago

Wockhardt gets QIDP status for pneumonia drug from USFDA

India | New Delhi May 21, 2015 Last Updated at 17:57 IST Drug firm Wockhardt today said a product from its new drug discovery programme, which aims to treat pneumonia, has received QIDP status from the US health regulator. Qualified Infectious Disease Product ...
 Business Standard1 week ago Wockhardt to recall some products manufactured in India from US [Mint, New Delhi]  Bloomberg1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - usfda
Get updated on latest news & your favorite topics right in your inbox!
More     Less